https://www.statnews.com/pharmalot/2020/08/10/seizing-on-indias-lax-standards-for-covid-19-drugs-critics-push-for-an-overhaul-on-transparency/?utm_source=STAT+Newsletters&utm_campaign=59caa2594c-Daily_Recap&utm_medium=email&utm_term=0_8cab1d7961-59caa2594c-149692869

STAT Plus: Seizing on India’s lax standards for Covid-19 drugs, critics push for an overhaul on transparency

By ED SILVERMAN

RAFIQ MAQBOOL/AP

The critics have long complained that government oversight of its pharmaceutical industry is lax, but the issue has intensified because of Covid-19.

READ MORE